NRNP 6552 Women's Health Midterm Exam 2026 – Verified Questions and Answers | 100% Graded A+

NRNP 6552 Women's health Midterm Exam
cW cW cW cW cW




Questions with Correct Answers 2026
cW cW cW cW




100% Graded A+ cW cW




Question 1 cW 0/1
Serum cWFSH cWindirectly cWmeasures cWovarian cWfunction, cWwith levels cWof cWFSH
cWindicating cWnormally cWfunctioning cWovaries.



A cWLower
.
B cW Media
n
. cW
C cWHighe
r
. cW
D cWAbsen
t
. cW

Question 2 1/1
cW cW

Endometrial c W polyps c W are c W most c W commonly c W identified c W by:

A c W A c W speculum c W exam
.
B c W A c W bimanual c W exam
.
C c W A c W pap c W smear
.
D cWA c W transvaginal
ultrasound
.

Question 3 cW 1/1
Clinicians c W can c W participate c W in c W primary c W sexual c W violence c W prevention c W by
c W applying c W individual cWprevention cWskills, cWsuch cWas:



A c W Challenging c W behaviors c W in c W others c W that c W promote
violence
.
B c W Engaging c W in c W healthy c W professional c W and c W personal
relationships
.
C c W Learning c W to c W identify c W risk c W factors c W for c W sexually c W abusive
behaviors
.

, D cWB c W and c W C
.




E c W A, c W B, c W and c W C
.

Question 4 cW 1/1
A c W waiting c W period c W of between c W bariatric c W surgery c W and c W pregnancy c W is
c W recommended.
6-12
A cW
months
. cW
B c W 6-18
months
. cW
C c W 12-24
months
. cW
D cW3-5 c W years
.

Question 5 cW 1/1
Barriers c W for c W providers c W related c W to c W intimate c W partner c W violence c W screening c W include:

A c W Discomfort c W with c W the c W topic
.
B c W Having c W too c W much c W power c W that c W might c W be
intimidating
.
C c W Time c W constraints
.
D cWA c W and c W C
.
E c W A, c W B, c W and c W C
.

Question 6 cW 1/1
Hirsutism c W is c W defined c W as:

A c W Excessive c W terminal c W hair c W loss c W in
women
. cW
B c W Excessive c W nail c W growth c W in c W women
.
C c W Brittle c W nail c W growth c W in c W women
.
D c W Excessive c W terminal c W hair c W growth c W in
women
. cW

,Question 7 cW 0/1
A pharmacologic
c W c W treatment c W for c W patients c W with c W Hydradenitis c W Suppurativa c W (HI)
c W may c W include
A cWClindamycin
.
B cWMinocycline
.

C cWMetformin
.
D cWAll c W of c W the
above
. cW cW

Question 8 cW 1/1
When c W looking c W from c W a c W feminist c W perspective c W at c W research c W studies, c W one c W of
c W the c W great c W concerns c W is cWthat:



A c W There c W are c W too c W many c W studies c W involving c W women
.
B c W Most c W of c W the c W research c W is c W qualitative, c W which c W limits c W the c W applicability
.
C c W For c W many c W years, c W studies c W were c W done c W primarily c W on c W men c W with c W the c W findings
c W being
generalized c W to c W women
.
D cW None c W of c W the c W above
.



Question 9 1/1 cW cW

Most c W malignancies c W in c W breast c W tissue c W occur c W in:

A c W The c W areolar c W area
.
B cW The c W upper c W outer
quadrant
. cW
C c W The c W lower c W outer
quadrant
. cW
D cW None c W of c W the c W above
.

Question 10 cW 0/1
On vaginal c W exam
c W c W you c W find c W that c W Polly’s c W cervix c W is c W in c W the c W most c W common c W position,
c W which c W is:

A cWAnterior

, .
B cWMidline
.
C cWPosterior
.
D cWRetroflex
ed
. cW